Neoadjuvant therapy of juvenile angiofibroma of the nasopharynx and base of the skull with good clinical outcome (clinical case)
Juvenile nasopharyngeal angiofibroma is a benign, highly vascularized tumor that occurs mainly in children and young men of pubertal age 9-19 years old. Often manifested by difficulty in nasal breathing and nosebleeds. We report a 16-year-old boy with complaints of a complete absence of nasal breath...
Saved in:
| Main Authors: | I. N. Vorozhtsov, N. S. Grachev, E. I. Chechev, A. S. Krasnov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-06-01
|
| Series: | Опухоли головы и шеи |
| Subjects: | |
| Online Access: | https://ogsh.abvpress.ru/jour/article/view/971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative study between preoperative embolization and non embolization in juvenile nasopharyngeal angiofibroma resection
by: Tahany Rabie, et al.
Published: (2025-07-01) -
Effectiveness and safety of topical sirolimus in children with angiofibromas and tuberous sclerosis complex
by: Andrea Fernández de Lara-Arrieta, et al.
Published: (2025-04-01) -
Juvenile angiofibroma: a case report
by: Tiago Lourenço Coelho, et al.
Published: (2022-03-01) -
The Therapeutic Potential of Oral Everolimus for Facial Angiofibromas in Pediatric Tuberous Sclerosis Complex: A Case-Based Analysis of Efficacy
by: George Imataka, et al.
Published: (2024-12-01) -
Systematic surgical approach to juvenile angiofibroma
by: Raluca Oana Pulpă, et al.
Published: (2024-04-01)